Skip to search formSkip to main contentSkip to account menu

indacaterol 0.075 MG Inhalant Powder

Known as: indacaterol 75 MCG Inhalant Powder Capsule, indacaterol (as indacaterol maleate) 75 MCG Inhalant Powder Capsule, INDACATEROL 75MCG CAP,INHL,30 [VA Product] 
National Institutes of Health

Related topics

Related topics

5 relations
Adrenergic beta2-Agonists [MoA]AsthmaInhalant Powderindacaterol

Narrower (1)

indacaterol 0.075 MG Inhalant Powder [Arcapta]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Efficacy and Safety of Indacaterol/Glycopyrronium (IND/GLY) Versus Salmeterol/Fluticasone in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: The Chinese Cohort from…
ABSTRACT Inhaled indacaterol/glycopyrronium fixed-dose combination (IND/GLY) is approved in over 80 countries, including the EU… 
2016
2016
P60 Effect of Indacaterol/Glycopyrronium (IND/GLY) on patient-reported outcomes in men and women with COPD: a pooled analysis from the ignite programme
Introduction Literatures, although limited, suggest differences in the manifestations of COPD in terms of symptoms and health… 
2016
2016
Cardiovascular (CV) safety of indacaterol/glycopyrronium (IND/GLY) compared with salmeterol/fluticasone combination (SFC) in moderate-to-very severe COPD patients with prior exacerbations: The FLAME…
Introduction LABA/ ICS combination and/or LAMA are recommended as the first-choice of treatment for COPD patients (pts) with high… 
2016
2016
Es wird eng für inhalative Steroide bei COPD
  • CME
  • 2016
  • Corpus ID: 263521195
2016
2016
Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study
Introduction According to current GOLD strategy combined COPD assessment, patients with severe to very severe COPD, high risk of… 
2016
2016
Durchfälle in der Hausarztpraxis
„Für die meisten COPD-Patienten ist die duale Bronchodilatation mit einem LAMA und einem LABA die e ektivste erapie“, so Welte… 
2016
2016
COPD-Exazerbationsprophylaxe: Indacaterol-Glycopyrronium versus Salmeterol-Fluticason
Hintergrund. Bei Patienten, die nur mit einem langwirksamen Bronchodilatator (LABA oder LAMA) behandelt werden und weiterhin… 
2015
2015
P140 Effects of indacaterol/glycopyrronium on lung function and physical activity in patients with moderate to severe COPD
Rationale Indacaterol/glycopyrronium (IND/GLY, QVA149) is a combination of a long-acting beta-2 agonist and a muscarinic receptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)